Q4 2026 Earnings

EX-99.1 2 pahc-20260826xex99d1.htm EX-99.1 ​ Exhibit 99.1 ​ For Immediate Release ​ Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance ​ TEANECK, N.J., August 26, 2026 (Business Wire) – Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2026 and provided its financial guidance for the fiscal year ending June 30, 2027. ​ Highlights for the three months ended June 30, 2026 (compared to the three months ended June 30, 2025) ​ - Net sales of $396.7 million, an increase of $18.1 million, or 5% - Net income of $21.7 million, an increase of $4.5 million, or 26% - Diluted earnings per share of $0.53, an increase of $0.11, or 26% - Adjusted EBITDA of $64.2 million, an increase of $14.3 million, or 29% - Adjusted net income of $3...